M&A Deal Summary |
|
---|---|
Date | 2024-07-09 |
Target | Aker BioMarine - Feed Ingredients Business |
Sector | Life Science |
Buyer(s) | American Industrial Partners |
Sellers(s) | Aker BioMarine ASA |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1989 |
PE ASSETS | 10.0B USD |
Size | Mega |
Type | Sector Focused |
American Industrial Partners is a private equity firm focused on investments in North American manufacturing or industrial service companies. For platform acquisitions, the Firm seeks businesses with at least $500 million of revenue and the Firm will consider transactions valued up to $2 billion. Operating characteristics of prospective businesses include historical record of strong free cash flows, opportunities to drive value through operating enhancements, and sustainable competitive advantages. American Industrial Partners will consider a variety of transaction types including leveraged buyouts, structured equity investments, bridge financings, senior debt, carve-outs, take privates, turnarounds, and rescue financings. American Industrial Partners was formed in 1989 and is based in New York City.
DEAL STATS | # |
---|---|
Overall | 50 of 53 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 16 of 19 |
Country (Norway) | 1 of 1 |
Year (2024) | 3 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-07-01 |
Austin Powder
Cleveland, Ohio, United States Austin Powder offers manufacturing, distributing, and application of industrial explosives for quarrying, surface mining, underground mining, oil and gas, seismic, and construction markets. The company provides a broad range of highly engineered solutions all of which are developed to advance the safety, reliability, and efficiency of breaking rock. Austin Powder was formed in 1833 and is based in Cleveland, Ohio. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-07-25 |
AGCO - Grain & Protein Division
Duluth, Georgia, United States AGCO's Grain & Protein Division designs manufactures, and globally markets grain storage and seed processing equipment and solutions as well as feeding, watering, climate management, and control systems for worldwide protein production, principally poultry, swine, and egg. |
Buy | $700M |
Aker BioMarine is an integrated biotechnology company – uniquely positioned to create value from krill harvesting and processing.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Divestiture) | 1 of 1 |
Country (Norway) | 1 of 1 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-11-01 |
Trygg Pharma
Oslo, Norway Trygg Pharma is a Norwegian-based 50/50 joint venture with Aker BioMarine. TPH is a manufacturer of marine-based omega-3 EPA/DHA concentrates for nutraceutical and pharmaceutical applications. EPAX, TPH’s nutraceutical division, is a long-standing leader in marine-based omega-3 EPA/DHA fatty acid concentrates for nutraceutical manufacturers and marketers, with a focus on the high concentrate segment. Trygg Pharma, TPH’s pharmaceutical division, is completing a Phase III FDA study on an omega-3-based drug candidate for hypertriglyceridemia. Trygg Pharma was founded in 2009 and is based in Oslo, Norway. |
Buy | - |